Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors
SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--Structure Therapeutics Inc., a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced the appointments of Eric Dobmeier and Joanne Waldstreicher, M.D., to its Board of Directors. “We welcome both Eric and Joanne, who will be invaluable to...
